Community/Retail

Cases highlight an acute subdural hematoma and chronic obstructive pulmonary disease.

Despite this decision, the trend of various states attempting to regulate pharmacy benefit managers is expected to continue

Moving cannabis to Schedule 3 will make it easier to research, resulting in the development and creation of new cannabinoid-based pharmaceuticals, with notable potential in oncology.

A supplemental New Drug Application will be submitted for roflumilast cream 0.05% for the treatment of mild to moderate atopic dermatitis in children 2 to 5 years of age.

An average patient with heart failure can take up to 6 medications for guideline-directed medical therapy; however, they may have other comorbidities that require pharmacologic management.

Pharmacists play a vital role in providing education and administering influenza, COVID-19, and RSV Vaccines

Shared decision-making can be better incorporated into cardiovascular care guidelines by including decision aids, such as informational flyers or online tools to help patients.

Moderna has advanced 6 programs into late-stage development, including for respiratory conditions, latent and other viruses, oncology, and rare diseases.

Insulin glargine-yfgn is more affordable than the reference product and patients do not require prescriber authorization switch.

Infections were associated with a 1.49-fold increase in the rate of dementia in both the short- and long-term rates, however, the increases were greater in the short term.

Supplemental biologics license application is based on positive results from the phase 3 XTEND-Kids study, demonstrating highly effective bleed protection with once weekly dosing of Altuviiio for children with severe hemophilia A.

In addition to identifying strategies to reduce the adverse effects of sleep and circadian disruption, the study authors identify the impact of obesity on sleep.

Research shows a peak of highly cited COVID-19 studies at the end of 2021 and a significant downward trend by the end of 2022.

Strategies include improving compliance, convenience, symptom management, and reducing stigma around pre-exposure prophylaxis for HIV.

Combining strong evidence-based recommendations with caring, compassionate, and frequent counseling opportunities hopefully will increase vaccine acceptance and ultimately reduce the incidence of HPV and associated cancers among our patients.

Pharmacist successfully mounts challenge to that limitation.

Experts answer questions on influenza vaccines.

In this episode of Pharmacy Focus: Student Edition, we dive deep into the world of scholarship funds from Good Neighbor Pharmacy and Cencora, designed to support Black student pharmacists.

Study results could lead to an FDA approval for MDMA to treat post-traumatic stress disorder by the end of 2023.

Community pharmacies and organizations can collaborate to tailor strategies and interventions and address the challenges and specific needs of the community.

With some of the most effective antidepressants containing a black box warning, safe and effective treatment for young adults is hard to come by.

Products include Cyanocobalamin Nasal Spray, Chlorpromazine Hydrochloride Tablets USP, Tiotropium Bromide Inhalation Powder, 18 mcg/ capsule, and Sevelamer Hydrochloride Tablets USP.

As a once-daily oral treatment, orforglipron could help address barriers to injectable medications, such as semaglutide and liraglutide.

Expert panelists addressed concerns about the COVID-19 vaccine costs, availability, efficacy, and timing.

Products include Nirsevimab-alip, Remdesivir, Inclisiran, and Lecanemab-irmb.

By educating their patients on the provisions of the Inflation Reduction Act, pharmacists can have an even greater impact by increasing vaccine uptake in historically underserved groups.

Heart disease prevention efforts should acknowledge non-biological factors that can cause issues within cardiovascular health rather than relying on decreasing socioeconomic disparities.

Clinicians raise concerns about immunogenicity, product quality, and reimbursement for biosimilars.

Compared with COVID-19 vaccination alone, recent study findings show health care workers who received both a COVID-19 booster and influenza vaccinations did not have lower immune response or more frequent adverse events.